Dynavax Technologies (DVAX)
(Delayed Data from NSDQ)
$11.76 USD
-0.08 (-0.63%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $11.75 -0.01 (-0.09%) 5:50 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Price, Consensus and EPS Surprise
DVAX 11.76 -0.08(-0.63%)
Will DVAX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DVAX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DVAX
Dynavax Technologies (DVAX) Reports Break-Even Earnings for Q4
Pacira (PCRX) Preliminary '23 Revenues Solid, Exparel Strong
DVAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Axsome (AXSM) Stock Rises on Stellar Q4 Preliminary Results
Dynavax Technologies (DVAX) Is a Great Choice for 'Trend' Investors, Here's Why
Collegium (COLL) Shares Rise on Financial Outlook for 2024
Other News for DVAX
Dynavax Appoints Interim CFO During MacDonald’s Leave
Dynavax Technologies: Still A Believer
Dynavax: Holding Firm Despite Its Missing Cash Cow
Dynavax (NASDAQ:DVAX): Potential Growth at a Rich Valuation
Dynavax (NASDAQ:DVAX): Robust Growth at a Rich Valuation